Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000049.xml
Clin Colon Rectal Surg 2015; 28(04): 262-270
DOI: 10.1055/s-0035-1564435
DOI: 10.1055/s-0035-1564435
Surveillance and Survivorship after Treatment for Colon Cancer
Further Information
Publication History
Publication Date:
22 November 2015 (online)
![](https://www.thieme-connect.de/media/ccrs/201504/lookinside/thumbnails/10-1055-s-0035-1564435_00703-1.jpg)
Abstract
Colorectal cancer is the third most common cancer diagnosed in the United States. Majority of patients have localized disease that is amenable to curative resection. Disease recurrence remains a major concern after resection. In addition, patients are at an increased risk for developing a second or metachronous colon cancer. The principal goal of surveillance following treatment of colon cancer is to improve disease-free and overall survival. Survivorship is a distinct phase following surveillance to help improve quality of life and promote longevity.
-
References
- 1 Anthony T, Simmang C, Hyman N , et al; Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004; 47 (6) 807-817
- 2 Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53 (1) 5-26
- 3 Goldberg RM, Fleming TR, Tangen CM , et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129 (1) 27-35
- 4 Engstrom PF, Benson III AB, Saltz L ; National Comprehensive Cancer Network. Colon cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003; 1 (1) 40-53
- 5 Engstrom PF, Benson III AB, Saltz L ; National Comprehensive Cancer Network. Rectal cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003; 1 (1) 54-63
- 6 Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38 (6) 619-626
- 7 Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130 (10) 1062-1067
- 8 Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84 (5) 666-669
- 9 Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114 (1) 7-14
- 10 Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998; 41 (9) 1127-1133
- 11 Secco GB, Fardelli R, Gianquinto D , et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002; 28 (4) 418-423
- 12 Primrose JN, Perera R, Gray A , et al; FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014; 311 (3) 263-270
- 13 Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324 (7341) 813-813
- 14 Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007; (1) CD002200
- 15 Figueredo A, Rumble RB, Maroun J , et al; Follow-up of patients with curatively resected colorectal cancer: a practice guideline. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. BMC Cancer 2003; 3: 26
- 16 Rosen M, Chan L, Beart Jr RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998; 41 (9) 1116-1126
- 17 Pfister DG, Benson III AB, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004; 350 (23) 2375-2382
- 18 Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998; 228 (1) 59-63
- 19 Stiggelbout AM, de Haes JC, Vree R , et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997; 75 (6) 914-920
- 20 Wattchow DA, Weller DP, Esterman A , et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006; 94 (8) 1116-1121
- 21 Peethambaram P, Weiss M, Loprinzi CL , et al. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology 1997; 54 (4) 287-292
- 22 Graffner H, Hultberg B, Johansson B, Möller T, Petersson BG. Detection of recurrent cancer of the colon and rectum. J Surg Oncol 1985; 28 (2) 156-159
- 23 Ahlquist DA, Wieand HS, Moertel CG , et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 269 (10) 1262-1267
- 24 Jahn H, Joergensen OD, Kronborg O, Fenger C. Can Hemoccult-II replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy?. Dis Colon Rectum 1992; 35 (3) 253-256
- 25 Locker GY, Hamilton S, Harris J , et al; ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24 (33) 5313-5327
- 26 Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999; 23 (7) 721-726
- 27 Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270 (8) 943-947
- 28 Lennon T, Houghton J, Northover JM , et al. What is the value of clinical follow-up for colorectal cancer patients?. The experience of the CRC/NIH CEA second-look trial—Proceedings of the Nottingham International Colorectal Cancer Symposium, Nottingham; 1995
- 29 Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer. JAMA 1994; 272 (1) 31
- 30 Litvak A, Cercek A, Segal N , et al. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Canc Netw 2014; 12 (6) 907-913
- 31 Ding P, Liska D, Tang P , et al. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg 2012; 256 (1) 111-116
- 32 Li Destri G, Di Cataldo A, Puleo S. Colorectal cancer follow-up: useful or useless?. Surg Oncol 2006; 15 (1) 1-12
- 33 Glover C, Douse P, Kane P , et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002; 45 (4) 476-484
- 34 Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Dis Colon Rectum 2005; 48 (4) 744-748
- 35 Rex DK, Kahi CJ, Levin B , et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006; 56 (3) 160-167 , quiz 185–186
- 36 Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD. Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 2010; 53 (10) 1365-1373
- 37 Green RJ, Metlay JP, Propert K , et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 2002; 136 (4) 261-269
- 38 Earle C, Annis R, Sussman J, Haynes AE, Vafaei A. Follow-up Care, Surveillance Protocol, and Secondary Prevention Measures for Survival of Colorectal Cancer. Toronto, ON: Cancer Care Ontario; 2012
- 39 Rowland JH. What are cancer survivors telling us?. Cancer J 2008; 14 (6) 361-368
- 40 Labianca R, Nordlinger B, Beretta GD , et al; ESMO Guidelines Working Group. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl. 06) vi64-vi72
- 41 Baker F, Haffer SC, Denniston M. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 2003; 97 (3) 674-681
- 42 Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer 2008; 112 (11, Suppl): 2577-2592
- 43 Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 2009; 7 (8) 883-893 , quiz 894
- 44 Kurtz ME, Kurtz JC, Stommel M, Given CW, Given B. Predictors of depressive symptomatology of geriatric patients with colorectal cancer: a longitudinal view. Support Care Cancer 2002; 10 (6) 494-501
- 45 Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 2013; 31 (21) 2699-2707
- 46 Gami B, Harrington K, Blake P , et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2003; 18 (10) 987-994
- 47 Meyerhardt JA, Sato K, Niedzwiecki D , et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012; 104 (22) 1702-1711
- 48 Meyerhardt JA, Heseltine D, Niedzwiecki D , et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006; 24 (22) 3535-3541
- 49 Meyerhardt JA, Giovannucci EL, Ogino S , et al. Physical activity and male colorectal cancer survival. Arch Intern Med 2009; 169 (22) 2102-2108
- 50 Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 2013; 31 (7) 876-885
- 51 Kuiper JG, Phipps AI, Neuhouser ML , et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012; 23 (12) 1939-1948
- 52 Je Y, Jeon JY, Giovannucci EL, Meyerhardt JA. Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer 2013; 133 (8) 1905-1913
- 53 Dignam JJ, Polite BN, Yothers G , et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98 (22) 1647-1654
- 54 Sinicrope FA, Foster NR, Yoon HH , et al. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol 2012; 30 (4) 406-412
- 55 Sinicrope FA, Foster NR, Yothers G , et al; Adjuvant Colon Cancer Endpoints (ACCENT) Group. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 2013; 119 (8) 1528-1536
- 56 Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30 (1) 42-52
- 57 Meyerhardt JA, Niedzwiecki D, Hollis D , et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007; 298 (7) 754-764
- 58 Kushi LH, Byers T, Doyle C , et al; American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006; 56 (5) 254-281 , quiz 313–314
- 59 Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V. Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol 2011; 29 (24) 3263-3269
- 60 Meyerhardt JA, Mangu PB, Flynn PJ , et al; American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013; 31 (35) 4465-4470
- 61 Faul LA, Shibata D, Townsend I, Jacobsen PB. Improving survivorship care for patients with colorectal cancer. Cancer Contr 2010; 17 (1) 35-43
- 62 Hewitt M, Greenfield S, Stovall E , eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Committee on Cancer Survivorship: Improving Care and Quality of Life. Institute of Medicine and National Research Council: National Academy of Sciences; 2006
- 63 McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol 2013; 31 (22) 2773-2782
- 64 Phipps AI, Shi Q, Newcomb PA , et al. Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol 2013; 31 (16) 2016-2023
- 65 Benson III AB, Bekaii-Saab T, Chan E , et al; National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013; 11 (5) 519-528
- 66 Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004; 101 (8) 1712-1719